How Organizations Can Lower Their Risks of Diversion
While there will never be a perfect solution to preventing drug diversion 100% of the time, leveraging the right people, processes and technology is our best chance of keeping patients safe.
Tom Knight and Karen Kobelski
Tom Knight is the founder of Invistics, now part of Wolters Kluwer. Prior to founding Invistics, Tom spent 10 years improving supply chains as a manufacturing manager at Alcoa and Siemens.
Karen Kobelski, Vice President and General Manager of Clinical Surveillance Compliance and Data Solutions, at Wolters Kluwer. With more than 25 years of leadership experience, Karen Kobelski is an innovative leader in healthcare technology with multi-disciplined, global experience in driving market-leading solutions that provide clinical surveillance, risk detection and data normalization to improve the quality of patient care, regulatory compliance, and operational performance of organizations in the healthcare industry.